Latest News & Articles

For yet another year, ophthalmic surgeon Konstantinos Chatzinikolas participated in the annual conference on intraocular lenses and refractive surgery, held at the HILTON Hotel in Athens.

The drug QLT091001 is entering a phase 2a clinical trial to evaluate its effectiveness in retinitis pigmentosa.

Oral administration of the tyrosine kinase inhibitor (pazopanib) shows promising early results in patients with age related macular degeneration.

The ophthalmic surgeon Dr. Konstantinos Chatzinikolas participated in the World Congress of the European Society of Cataract and Refractive Surgeons, which took place in Amsterdam, the Netherlands, from October 5 to 9, 2013.

A wireless artificial implant placed in the space beneath the retina has been approved for human use in Europe due to its strong clinical results.

A new study published in the journal Nature concluded that the eyes need natural light to develop normally during pregnancy.